Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 23Thoracic 3Gastrointestinal 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Genitourinary 2Breast 2Myeloid 1Head & Neck 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 11Leukemia, Myeloid, Acute 8Myeloproliferative Disorders 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Polycythemia Vera 3Lymphoma, Non-Hodgkin 3Leukemia 3Thrombosis 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myeloid, Accelerated Phase 2Hodgkin Disease 2Hematologic Neoplasms 2Blast Crisis 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urticaria Pigmentosa 1Thrombocythemia, Essential 1Pyruvate Kinase Deficiency of Red Cells 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Pathologic Complete Response 1Ovarian Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Mastocytosis, Cutaneous 1Lymphoproliferative Disorders 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1

Interventions

Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Fentanyl 1Drug Therapy 1Dalteparin 1Blood Specimen Collection 1Biological Therapy 1Antineoplastic Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Blood Specimen Collection × Myeloid × Clear all
NCT02016833 2015-04-30

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

PX Biosolutions

Completed
15 enrolled
GynecologicMyeloidOther hematologic neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Leukemia, Ovarian Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡